Structural optimization of novel 1,3,4-oxadiazole-based antibacterial compounds for improved stability.
The design and evaluation of analogues aimed at improving metabolic stability while defining the structural features required for antibacterial activity are described and key insights that may aid in identifying the compound's molecular target are provided.